Insider Transactions in Q1 2022 at Willis Towers Watson PLC (WTW)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.4%
|
$310,800
$222.3 P/Share
|
|
Feb 28
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,300
-6.86%
|
$722,700
$219.26 P/Share
|
|
Feb 28
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+6.42%
|
$363,000
$110.58 P/Share
|
|
Feb 25
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,300
-3.25%
|
$726,000
$220.91 P/Share
|
|
Feb 25
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+6.03%
|
$363,000
$110.58 P/Share
|
|
Feb 22
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.22%
|
$23,625
$225.61 P/Share
|
|
Feb 22
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,525
+8.58%
|
-
|
|
Feb 22
2022
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
3,248
+19.52%
|
-
|
|
Feb 22
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-0.15%
|
$25,425
$225.61 P/Share
|
|
Feb 22
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
4,525
+5.75%
|
-
|
|
Feb 22
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-0.11%
|
$25,650
$225.61 P/Share
|
|
Feb 22
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
4,525
+4.33%
|
-
|
|
Feb 22
2022
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,480
+11.89%
|
-
|
|
Feb 22
2022
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
3,274
+20.33%
|
-
|
|
Feb 22
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
82
-0.57%
|
$18,450
$225.61 P/Share
|
|
Feb 22
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,958
+16.96%
|
-
|
|
Feb 22
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,000
-5.16%
|
$446,000
$223.9 P/Share
|
|
Feb 14
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
2,400
-2.45%
|
$528,000
$220.99 P/Share
|
|
Jan 03
2022
|
Michelle R Swanback Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+50.0%
|
-
|
|
Jan 03
2022
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+50.0%
|
-
|
|
Jan 03
2022
|
Inga K Beale Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+50.0%
|
-
|
|
Jan 03
2022
|
Victor F Ganzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
265
+1.17%
|
-
|